课题基金 / 基金详情

SHORT COURSE PROMACE-CYTABOM FOR STAGES II-IV DIFFUSE AGGRESSIVE LYMPHOMA

SHORT COURSE PROMACE-CYTABOM FOR STAGES II-IV DIFFUSE AGGRESSIVE LYMPHOMA
用于治疗 II-IV 期弥漫性侵袭性淋巴瘤的短期疗程 PROMACE-CYTABOM
批准号:
3874545
负责人:
D L LONGO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D L LONGO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study was designed as a pilot study to test the feasibility and efficacy of administering a dose-intense version of a standard combination chemotherapy regimen ProMACE-CytaBOM for patients with Stages II, III, and IV diffuse aggression lymphoma. The treatment consists of eight 2-week cycles, for a total of sixteen weeks. To date, there have been 23 evaluable patients entered on study: nineteen have achieved a complete response (83%). There have been 6 relapses (32%), all following short complete remissions. In conclusion, these preliminary results indicate that the treatment can be safely given, though some patients require dose- reductions. Early response rates are equivalent to standard ProMACE- CytaBOM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREATMENT OF B-CELL LYMPHOMAS WITH ANTI-B4-BLOCKED RICIN IMMUNOCONJUGATE
  • 批准号:
    3838244
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L LONGO
  • 依托单位:
MOPP VS RADIOTHERAPY FOR EARLY STAGE HODGKIN'S DISEASE
  • 批准号:
    3838209
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L LONGO
  • 依托单位:
5FU, LEUCOVORIN, AZT & PERSANTINE FOR MELANOMA, RENAL, AND COLORECTAL CANCER
  • 批准号:
    3838218
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L LONGO
  • 依托单位:
TREATMENT OF STAGE I DIFFUSE AGGRESSIVE LYMPHOMAS
  • 批准号:
    3853324
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L LONGO
  • 依托单位:
海外基金